Biotech Values

[lgonber]

BLCM. I remember going through that when holding JUNO. Stock went from $30 to $20 on a clinical hold because of 2 patients death. The stock recovered 7 months after the clinical hold. And as we all know, it got BO last week at $86. Not saying is exactly the same, plus that BLCM program on hold is not a "strict" CAR-T cell program. But, I think it will recover.
I have the impression thought that KITE and JUNO are loved and BLCM has no love in the stock Market (actually the 2 first have been taken already)